[{"address1": "No. 312, 71 Commercial Street", "city": "Boston", "state": "MA", "zip": "02109", "country": "United States", "phone": "617 313 8853", "website": "https://www.akiliinteractive.com", "industry": "Health Information Services", "industryKey": "health-information-services", "industryDisp": "Health Information Services", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Akili, Inc., a digital medicine company, develops cognitive treatments through game-changing technologies. The company provides EndeavorRx, a computer-based testing for cognitive dysfunction across several neurology and psychiatry indications, including attention-deficit hyperactivity disorder, depressive disorder, autism spectrum disorder, multiple sclerosis, and other neuroinflammatory diseases. It also offers selective stimulus management engine mechanism to activate the fronto-parietal cortex area in the brain; body brain trainer for attention, impulsivity, working memory, and goal management; and spatial navigation engine for spatial navigation, memory, and planning and organization. The company was founded in 2011 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 68, "companyOfficers": [{"maxAge": 1, "name": "Dr. Walter Edward Martucci II, Ph.D.", "age": 40, "title": "Co-Founder & Chairman", "yearBorn": 1983, "fiscalYear": 2023, "totalPay": 759099, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew  Franklin M.B.A.", "age": 49, "title": "President, CEO & Director", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 639133, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Adam  Gazzaley M.D., Ph.D.", "age": 53, "title": "Co-Founder, Chief Science Advisor & Director", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 126452, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jacqueline L. Studer J.D.", "age": 64, "title": "Chief Legal Officer, General Counsel & Secretary", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 559550, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Caty  Reid", "title": "VP of Marketing & Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Scott H.  Kollins Ph.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jonathan  David", "age": 45, "title": "Chief Product Officer", "yearBorn": 1978, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.4088, "open": 0.4, "dayLow": 0.4, "dayHigh": 0.432, "regularMarketPreviousClose": 0.4088, "regularMarketOpen": 0.4, "regularMarketDayLow": 0.4, "regularMarketDayHigh": 0.432, "beta": 1.987, "forwardPE": -0.787451, "volume": 844839, "regularMarketVolume": 844839, "averageVolume": 3892117, "averageVolume10days": 9159390, "averageDailyVolume10Day": 9159390, "ask": 0.42, "askSize": 100, "marketCap": 31564234, "fiftyTwoWeekLow": 0.191, "fiftyTwoWeekHigh": 1.67, "priceToSalesTrailing12Months": 18.810629, "fiftyDayAverage": 0.29084, "twoHundredDayAverage": 0.52119, "currency": "USD", "enterpriseValue": -28135456, "floatShares": 26107657, "sharesOutstanding": 78596200, "sharesShort": 79612, "sharesShortPriorMonth": 176062, "sharesShortPreviousMonthDate": 1710460800, "dateShortInterest": 1713139200, "sharesPercentSharesOut": 0.001, "heldPercentInsiders": 0.23256001, "heldPercentInstitutions": 0.52755, "shortRatio": 0.31, "shortPercentOfFloat": 0.0021, "impliedSharesOutstanding": 78596200, "bookValue": 0.747, "priceToBook": 0.53761715, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -59493000, "trailingEps": -0.76, "forwardEps": -0.51, "enterpriseToRevenue": -16.767, "enterpriseToEbitda": 0.438, "52WeekChange": -0.69703704, "SandP52WeekChange": 0.22379243, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "AKLI", "underlyingSymbol": "AKLI", "shortName": "Akili, Inc.", "longName": "Akili, Inc.", "firstTradeDateEpochUtc": 1625059800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "07e8927c-4d6f-369c-9eac-62b851dab9d3", "messageBoardId": "finmb_213991723", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.4016, "targetHighPrice": 0.65, "targetLowPrice": 0.65, "targetMeanPrice": 0.65, "targetMedianPrice": 0.65, "recommendationMean": 2.5, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 75150000, "totalCashPerShare": 0.957, "ebitda": -64183000, "totalDebt": 15485000, "quickRatio": 5.819, "currentRatio": 6.018, "totalRevenue": 1678000, "debtToEquity": 26.456, "revenuePerShare": 0.021, "returnOnAssets": -0.35834998, "returnOnEquity": -0.70318, "freeCashflow": -36471876, "operatingCashflow": -57867000, "revenueGrowth": 5.748, "grossMargins": 0.51192003, "operatingMargins": -15.51802, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-05-04"}]